Bradley McEvoy
Electronic BioSciences (United States)(US)
Publications by Year
Research Areas
Amyloidosis: Diagnosis, Treatment, Outcomes, Schizophrenia research and treatment, Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, Mental Health and Psychiatry
Most-Cited Works
- → Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis(2018)1,389 cited
- → Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides(2017)574 cited
- → Trial of Pimavanserin in Dementia-Related Psychosis(2021)127 cited
- → The Effects of 2′- O -Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials(2017)120 cited
- → Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists(2011)80 cited
- → Missing data in clinical trials for weight management(2015)25 cited
- → Bayesian Approach for Clinical Trial Safety Data Using an Ising Prior(2013)11 cited
- → HARMONY Study: Pimavanserin Significantly Prolongs Time to Relapse of Dementia-Related Psychosis(2020)4 cited
- → 427 - HARMONY study: pimavanserin significantly reduces risk of relapse of dementia-related psychosis(2020)3 cited
- → An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1(2026)2 cited